We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+4.67%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$489B
AUM Growth
+$8.01B
Cap. Flow
-$30B
Cap. Flow %
-6.13%
Top 10 Hldgs %
29.25%
Holding
15,615
New
1,894
Increased
5,212
Reduced
6,339
Closed
1,910

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$1.71B
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$613M
3
AAPL icon
Apple
AAPL
+$478M
4
MA icon
Mastercard
MA
+$450M
5
QQQ icon
Invesco QQQ Trust
QQQ
+$424M

Sector Composition

Rank Sector Weight
1 Technology 3.12%
2 Financials 2.35%
3 Healthcare 2.22%
4 Consumer Discretionary 2.21%
5 Communication Services 1.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PLX icon
13526
PUT
Protalix BioTherapeutics
PLX
$179M
$13K ﹤0.01%
15,700
-54,100
-78% -$56.7K
TALKW
13527
DELISTED
Talkspace Inc Warrant
TALKW
$13K ﹤0.01%
53,696
+2,342
+5% +$1.13K
TLSA icon
13528
CALL
Tiziana Life Sciences
TLSA
$145M
$13K ﹤0.01%
13,600
-3,300
-20% -$4.37K
MACAW
13529
DELISTED
Moringa Acquisition Corp Warrant
MACAW
$13K ﹤0.01%
23,933
-18,562
-44% -$11.1K
ASLN
13530
PUT
DELISTED
ASLAN Pharmaceuticals Limited American Depositary Shares
ASLN
$13K ﹤0.01%
290
-1,560
-84% -$93.5K
COMS
13531
DELISTED
COMSovereign Holding Corp. Common Stock
COMS
$13K ﹤0.01%
171
-127
-43% -$14.9K
RCA
13532
DELISTED
Ready Capital Corporation 7.00% Convertible Senior Notes due 2023
RCA
0
MITO
13533
DELISTED
Stealth BioTherapeutics Corp. ADS
MITO
$13K ﹤0.01%
+16,213
New +$16.9K
NBRV
13534
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$13K ﹤0.01%
855
-2,020
-70% -$47.8K
KXIN icon
13535
CALL
Kaixin Holdings
KXIN
$8.43M
0
PHIO icon
13536
CALL
Phio Pharmaceuticals
PHIO
$12.7M
$12K ﹤0.01%
114
-1,048
-90% -$167K
TISI icon
13537
PUT
Team
TISI
$101M
$12K ﹤0.01%
+1,090
New +$21.8K
YCBD icon
13538
cbdMD
YCBD
$5.2M
$12K ﹤0.01%
30
-20
-40% -$11.6K
PKBOW
13539
DELISTED
Peak Bio, Inc. Warrant
PKBOW
$12K ﹤0.01%
15,289
LJAQW
13540
DELISTED
LightJump Acquisition Corporation Warrant
LJAQW
$12K ﹤0.01%
24,296
OTRAW
13541
DELISTED
OTR Acquisition Corp. Warrant
OTRAW
$12K ﹤0.01%
24,750
-95
-0.4% -$53
NBRV
13542
CALL
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$12K ﹤0.01%
824
-80
-9% -$1.89K
EVOK
13543
CALL
DELISTED
Evoke Pharma
EVOK
$11K ﹤0.01%
+134
New +$18.7K
MVSTW
13544
DELISTED
Microvast Holdings Warrants
MVSTW
$11K ﹤0.01%
+11,575
New +$20.4K
NINE
13545
PUT
DELISTED
Nine Energy Service
NINE
$11K ﹤0.01%
+10,500
New +$17.1K
TYME
13546
DELISTED
Tyme Technologies, Inc. Common Stock
TYME
$11K ﹤0.01%
18,708
-47,695
-72% -$41K
EVFM
13547
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
$11K ﹤0.01%
1,865
-7,161
-79% -$60.9K
NAVB
13548
CALL
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
$11K ﹤0.01%
10,700
-6,500
-38% -$9.15K
HGASW
13549
DELISTED
Global Gas Corporation Warrant
HGASW
$10K ﹤0.01%
21,587
-247,660
-92% -$177K
AAU
13550
CALL
DELISTED
Almaden Minerals Ltd
AAU
$10K ﹤0.01%
+34,500
New +$12.2K

Similar funds

Ken Griffin's Q4 2021 Portfolio in Review

As of Q4 2021, Ken Griffin held 15,615 positions worth $489B, up 1.7% from $481B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Ken Griffin withdrew a net $30B in Q4 2021, closing 1,910 positions and reducing 6,339 holdings. Its most notable exit was CIMAREX ENERGY CO, an estimated $279M position sold in full.

By sector, the portfolio is most concentrated in Technology at 3.1% of assets, up from 3.1% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Ken Griffin opened a new position in iShares iBoxx $ High Yield Corporate Bond ETF worth $248M.

  • Ken Griffin's largest Q4 2021 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 2,847,920 shares worth $248M.
  • Ken Griffin added most to Amazon in Q4 2021, an estimated $802M increase.
  • Ken Griffin's biggest Q4 2021 reduction was Tesla, cutting an estimated $1.71B.
  • Ken Griffin fully exited CIMAREX ENERGY CO in Q4 2021, selling an estimated $279M.
  • Ken Griffin's ten largest holdings make up 29% of its $489B portfolio in Q4 2021.
  • Ken Griffin opened 1,894 new positions and closed 1,910 in Q4 2021.
  • Ken Griffin's portfolio value rose 1.7% quarter-over-quarter to $489B.

Based on Citadel Advisors's 13F filing for Q4 2021, filed 14 Feb 2022.